A brief olfactory test for Alzheimer's disease

BACKGROUND The early diagnosis of Alzheimer's disease (AD) may help reduce disability, enhance quality of life, and aid clinical trials. Portions of olfactory cortex are the initial sites of AD pathology and patients with AD often have more degeneration of their left than right hemisphere. Since the olfactory epithelium projects mainly to the ipsilateral olfactory cortex, patients with AD may demonstrate an asymmetrical (left greater than right) decrement of odor detection sensitivity. This retrospective, case-control study assessed a quick olfactory test that may help diagnose AD. METHODS Participants with probable AD (N=18), mild cognitive impairment (MCI, N=24), other causes of dementia (OD, N=26) and matched controls (OC, N=26) were tested, with closed eyes, for their ability to detect an odor, one nostril at a time. A container of 14g of peanut butter was opened, held medially at the bottom of a 30cm ruler, and moved up 1cm at a time during the participants' exhale. Upon odor detection, the distance between the subject's nostril and container was measured. RESULTS The mean odor detection distance of AD patients' left nostril (5.1cm), and not their right (17.4cm), was significantly less (F(3,90)=22.28, p<0.0001) than the other groups. The mean, standard error, and 95% Confidence Interval of the L-R nostril odor detection difference (cm) for AD were -12.4±0.5, (-15.0,-9.8); for MCI were -1.9±1.2, (-4.2,0.4); for OD were 4.8±1.0, (2.6,6.9); and for OC were 0.0±1.4 (-2.2,2.1). CONCLUSION This non-invasive and inexpensive left-right nostril odor detection test appears to be a sensitive and specific test for probable AD.

[1]  K. Mori,et al.  The olfactory bulb: coding and processing of odor molecule information. , 1999, Science.

[2]  J. P. Morgan,et al.  Design and Analysis: A Researcher's Handbook , 2005, Technometrics.

[3]  Mark P. MacEachern,et al.  Olfactory identification testing as a predictor of the development of Alzheimer's dementia: A systematic review , 2012, The Laryngoscope.

[4]  G D Pearlson,et al.  Olfactory recognition: differential impairments in early and late Huntington's and Alzheimer's diseases. , 1987, Journal of clinical and experimental neuropsychology.

[5]  Murray Grossman,et al.  Comparison of cerebrospinal fluid levels of tau and Aβ 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms. , 2012, Archives of neurology.

[6]  J. Molinuevo,et al.  Applying the new research diagnostic criteria: MRI findings and neuropsychological correlations of prodromal AD , 2012, International journal of geriatric psychiatry.

[7]  Yaakov Stern,et al.  A 10‐item smell identification scale related to risk for Alzheimer's disease , 2005, Annals of neurology.

[8]  D. Neary,et al.  Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration , 2007, Neuropsychologia.

[9]  Sven Joubert,et al.  The effect of Alzheimer's disease and Parkinson's disease on olfaction: A meta-analysis , 2012, Behavioural Brain Research.

[10]  E. Kaplan,et al.  The Boston naming test , 2001 .

[11]  A. Allison,et al.  The secondary olfactory areas in the human brain. , 1954, Journal of anatomy.

[12]  J. Price,et al.  The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease , 1991, Neurobiology of Aging.

[13]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[14]  L A Beckett,et al.  Is the risk of developing Alzheimer's disease greater for women than for men? , 2001, American journal of epidemiology.

[15]  Xiaojing Sui,et al.  Cerebrospinal fluid biomarkers of Alzheimer’s disease , 2014, Neuroscience Bulletin.

[16]  R. Spiegel,et al.  Differences in olfactory test performance between normal aged, Alzheimer and vascular type dementia individuals , 1986 .

[17]  P. Moberg,et al.  Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. , 1998, Archives of neurology.

[18]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[19]  J. Haxby,et al.  Olfactory detection and identification performance are dissociated in early Alzheimer's disease , 1988, Neurology.

[20]  C. Jack,et al.  3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. , 2007, Brain : a journal of neurology.

[21]  Victor L. Villemagne,et al.  Brain Amyloid Imaging , 2011, The Journal of Nuclear Medicine.

[22]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[23]  C. Rowe,et al.  Olfactory performance in AD, aMCI, and healthy ageing: a unirhinal approach. , 2010, Chemical senses.

[24]  A. Benton.  Gerstmann's syndrome. , 1992, Archives of neurology.

[25]  J. Price,et al.  Central olfactory connections in the macaque monkey , 1994, The Journal of comparative neurology.

[26]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[27]  G. Busatto,et al.  Neurostructural predictors of Alzheimer's disease: A meta-analysis of VBM studies , 2011, Neurobiology of Aging.

[28]  Kaj Blennow,et al.  Cerebrospinal fluid protein biomarkers for Alzheimer’s disease , 2004, NeuroRX.

[29]  C. Tulleken,et al.  Odor discrimination in patients with frontal lobe damage and Korsakoff’s syndrome , 2002, Neuropsychologia.

[30]  E. Barragán,et al.  The olfactory system and Alzheimer's disease. , 1989, The International journal of neuroscience.

[31]  G. Schellenberg,et al.  Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E 4 status , 1999 .

[32]  A. Benton.  Development of a multilingual aphasia battery. Progress and problems. , 1969, Journal of the neurological sciences.

[33]  Allison Ac,et al.  The secondary olfactory areas in the human brain. , 1954 .

[34]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[35]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[36]  M Ennis,et al.  Functional organization of olfactory system. , 1996, Journal of neurobiology.

[37]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[38]  E B Larson,et al.  Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. , 1999, Neurology.

[39]  I. Grant,et al.  Odor sensitivity is impaired in HIV-positive cognitively impaired patients , 1996, Physiology & Behavior.

[40]  S. Pocock,et al.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, PLoS medicine.

[41]  T. Davidson,et al.  Rapid clinical evaluation of anosmia. The alcohol sniff test. , 1997, Archives of otolaryngology--head & neck surgery.

[42]  J. Brandt.  The Hopkins Verbal Learning Test: Development of a new memory test with six equivalent forms. , 1991 .